Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1992;71:646-656

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giannella-Neto, D.
Right arrow Articles by Fagin, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giannella-Neto, D.
Right arrow Articles by Fagin, J. A.

Circulation Research, Vol 71, 646-656, Copyright © 1992 by American Heart Association


ARTICLES

Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4

D Giannella-Neto, A Kamyar, B Sharifi, CJ Pirola, J Kupfer, RG Rosenfeld, JS Forrester and JA Fagin
Division of Cardiology, University of California, Los Angeles.

Platelet-derived growth factor (PDGF) is believed to be a critical mediator of vascular smooth muscle cell (SMC) proliferation. Because insulin-like growth factor (IGF) I (IGF-I) functions as a progression factor for the mitogenic effects of PDGF, we hypothesized that IGF-I gene expression and the production of IGF binding proteins (IGFBPs) by cultured rat aortic SMCs might be regulated by one or more of the three isoforms of PDGF: PDGF-AA, -BB, and -AB. IGF-I gene expression was highly dependent on cell density: IGF-I mRNA transcripts decreased markedly as a function of cell confluence. IGF-I mRNA content was inhibited to a similar degree by PDGF-AA, -BB, and -AB through a mechanism requiring protein synthesis. The inhibition was readily apparent at 4 hours, reaching approximately 25% of control levels after 24 hours. Radioimmunoassayable IGF-I was only barely detectable in SMC- conditioned serum-free medium and not significantly modulated by PDGF. Western ligand blot revealed that vascular SMCs release 30-kd and 24-kd IGFBP into serum-free conditioned medium. PDGF isoforms did not significantly alter release of the 30-kd IGFBP but evoked a fivefold to sixfold increase in the 24-kd IGFBP. The 24-kd IGFBP was found to comigrate with IGFBP-4, a recently identified binding protein that inhibits IGF action. The 30-kd protein was not merely a glycosylated form of IGFBP-4, because it was not sensitive to N-glycanase digestion. PDGF-AA, -BB, and -AB markedly induced expression of IGFBP-4 mRNA in a time- and concentration-dependent fashion. Vascular SMCs also express IGFBP-2 mRNA, but its abundance was not induced by PDGF. In conclusion, PDGF evokes a complex pattern of regulation of genes in the IGF/IGFBP system. By inhibiting IGF-I production and specifically inducing biosynthesis of the inhibitory binding protein IGFBP-4, PDGF may set in motion mechanisms to limit the final magnitude of the mitogenic response.


This article has been cited by other articles:


Home page
BloodHome page
F. Gieseke, B. Schutt, S. Viebahn, E. Koscielniak, W. Friedrich, R. Handgretinger, and I. Muller
Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFN{gamma}R1 signaling and IDO expression
Blood, September 15, 2007; 110(6): 2197 - 2200.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Delafontaine, Y.-H. Song, and Y. Li
Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Hsieh, R. E. Gordon, D. R. Clemmons, W. H. Busby Jr., and C. Duan
Regulation of Vascular Smooth Muscle Cell Responses to Insulin-like Growth Factor (IGF)-I by Local IGF-binding Proteins
J. Biol. Chem., October 31, 2003; 278(44): 42886 - 42892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang, E. P. Smith, H. Kuroda, W. Banach, S. D. Chernausek, and J. A. Fagin
Targeted Expression of a Protease-resistant IGFBP-4 Mutant in Smooth Muscle of Transgenic Mice Results in IGFBP-4 Stabilization and Smooth Muscle Hypotrophy
J. Biol. Chem., June 7, 2002; 277(24): 21285 - 21290.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. P. Smith, A. Kamyar, W. Niu, J. Wang, B. Cercek, S. D. Chernausek, and J. A. Fagin
IGF-Binding Protein-4 Expression and IGF-Binding Protein-4 Protease Activity Are Regulated Coordinately in Smooth Muscle During Postnatal Development and After Vascular Injury
Endocrinology, October 1, 2001; 142(10): 4420 - 4427.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Zhao, R. L. Sutliff, C. S. Weber, J. Wang, J. Lorenz, R. J. Paul, and J. A. Fagin
Smooth Muscle-Targeted Overexpression of Insulin-Like Growth Factor I Results in Enhanced Vascular Contractility
Endocrinology, February 1, 2001; 142(2): 623 - 632.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Wang and M. L. Adamo
Cell Density Influences Insulin-Like Growth Factor I Gene Expression in a Cell Type-Specific Manner
Endocrinology, July 1, 2000; 141(7): 2481 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Bayes-Genis, C. A. Conover, and R. S. Schwartz
The Insulin-Like Growth Factor Axis : A Review of Atherosclerosis and Restenosis
Circ. Res., February 4, 2000; 86(2): 125 - 130.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Anwar, A. A. Zahid, L. Phillips, and P. Delafontaine
Insulin-Like Growth Factor Binding Protein-4 Expression Is Decreased by Angiotensin II and Thrombin in Rat Aortic Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Duan, M. B. Liimatta, and O. L. Bottum
Insulin-like Growth Factor (IGF)-I Regulates IGF-binding Protein-5 Gene Expression through the Phosphatidylinositol 3-Kinase, Protein Kinase B/Akt, and p70 S6 Kinase Signaling Pathway
J. Biol. Chem., December 24, 1999; 274(52): 37147 - 37153.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Xin, N. Yang, and J. E. Faber
Platelet-Derived Growth Factor Inhibits alpha 1D-Adrenergic Receptor Expression in Vascular Smooth Muscle Cells In Vitro and Ex Vivo
Mol. Pharmacol., December 1, 1999; 56(6): 1143 - 1151.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. Yano, J. R. Bauchat, M. B. Liimatta, D. R. Clemmons, and C. Duan
Down-Regulation of Protein Kinase C Inhibits Insulin-Like Growth Factor I-Induced Vascular Smooth Muscle Cell Proliferation, Migration, and Gene Expression
Endocrinology, October 1, 1999; 140(10): 4622 - 4632.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Gustafsson, P. Andersson, Y. Chen, J. O. Magnusson, and H. J. Arnqvist
Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H499 - H507.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen
Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Rees, D. R. Clemmons, G. D. Horvitz, J. B. Clarke, and W. H. Busby
A Protease-Resistant Form of Insulin-Like Growth Factor (IGF) Binding Protein 4 Inhibits IGF-1 Actions
Endocrinology, October 1, 1998; 139(10): 4182 - 4188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Duan and D. R. Clemmons
Differential Expression and Biological Effects of Insulin-like Growth Factor-binding Protein-4 and -5 in Vascular Smooth Muscle Cells
J. Biol. Chem., July 3, 1998; 273(27): 16836 - 16842.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Wang, W. Niu, D. P. Witte, S. D. Chernausek, Y. E. Nikiforov, T. L. Clemens, B. Sharifi, A. R. Strauch, and J. A. Fagin
Overexpression of Insulin-Like Growth Factor-Binding Protein-4 (IGFBP-4) in Smooth Muscle Cells of Transgenic Mice through a Smooth Muscle {alpha}-Actin-IGFBP-4 Fusion Gene Induces Smooth Muscle Hypoplasia
Endocrinology, May 1, 1998; 139(5): 2605 - 2614.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. R. Sowers
Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology
Hypertension, March 1, 1997; 29(3): 691 - 699.
[Full Text]


Home page
Circ. Res.Home page
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien
The Intima : Soil for Atherosclerosis and Restenosis
Circ. Res., September 1, 1995; 77(3): 445 - 465.
[Full Text]


Home page
Circ. Res.Home page
A. Gockerman and D. R. Clemmons
Porcine Aortic Smooth Muscle Cells Secrete a Serine Protease for Insulin-like Growth Factor Binding Protein-2
Circ. Res., April 1, 1995; 76(4): 514 - 521.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. J. Scheidegger, R. W. James, and P. Delafontaine
Differential Effects of Low Density Lipoproteins on Insulin-like Growth Factor-1 (IGF-1) and IGF-1 Receptor Expression in Vascular Smooth Muscle Cells
J. Biol. Chem., August 25, 2000; 275(35): 26864 - 26869.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. A. Patel, Q.-J. Zhang, K. Siddle, M. A. Soos, M. Goddard, P. L. Weissberg, and M. R. Bennett
Defect in Insulin-Like Growth Factor-1 Survival Mechanism in Atherosclerotic Plaque-Derived Vascular Smooth Muscle Cells Is Mediated by Reduced Surface Binding and Signaling
Circ. Res., May 11, 2001; 88(9): 895 - 902.
[Abstract] [Full Text] [PDF]